Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Pavord (Leicester, United Kingdom). Anti-cytokine approaches should target bronchial hyperresponsiveness rather than inflammation – Pro. Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease

Member's Comments

No comment yet.

Related content which might interest you: Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 ILC2s in allergic airway inflammation Source: International Congress 2014 – Highlights from the Lung Science Conference 2014 Year: 2014 The development of an airway hyperresponsiveness (AHR) depends on mast cells following sensitization without adjuvant Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008 HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Allergen-induced airway remodelling Source: Eur Respir J 2007; 29: 1020-1032 Year: 2007 Rhinitis, nasal polyposis and asthma: pathological aspects Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115 Year: 2001 Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 The possible role of IL-5 and IFN-γ in the forming of cold airway hyperresponsiveness in patients with bronchial asthma Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13 Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models Source: Eur Respir J 2008; 32: 487-502 Year: 2008 Inhaled doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 Outgrown asthma does not mean no airways inflammation Source: Eur Respir J 2002; 19: 284-287 Year: 2002